Antibiotic Pharmacokinetic and Pharmacodynamic Considerations in Patients With Kidney Disease-Reference-Cited by-同舟云学术

Antibiotic Pharmacokinetic and Pharmacodynamic Considerations in Patients With Kidney Disease

Published:2010-09 Issue:5 Volume:17 Page:392-403
ISSN:1548-5595
Container-title:Advances in Chronic Kidney Disease
language:en
Short-container-title:Advances in Chronic Kidney Disease

Author:

Eyler Rachel F.,Mueller Bruce A.

Publisher

Elsevier BV

Subject

Nephrology

Reference67 articles.

1. United States Renal Data System: United States Renal Data System USRDS 2009 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009

2. Rational dosing of antimicrobial agents: Pharmacokinetic and pharmacodynamic strategies;Owens;Am J Health Syst Pharm,2009

3. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity;Rybak;Antimicrob Agents Chemother,1999

4. Pharmacodynamics and dosing of aminoglycosides;Turnidge;Infect Dis Clin North Am,2003

5. The pharmacodynamics of aminoglycosides;Lacy;Clin Infect Dis,1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the potential mechanism of antibacterial and anti-cancer activity of Angelicae Pubescentis radix based on network pharmacology and molecular docking technology;Panminerva Medica;2023-08

2. Infection and CKD;Evidence‐Based Nephrology;2022-11-18

3. The gut microbiome in chronic kidney disease;Human-Gut Microbiome;2022

4. Antibiotic Dosing in Chronic Kidney Disease;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products;2021-11-15

5. Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis;Drugs;2021-02-16